Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test

Parkinsonism and Related Disorders

Volumn 17, Issue 9, 2011, Pages 698-700

  Kikuchi, Akio ^a   Baba, Toru ^a   Hasegawa, Takafumi ^a   Sugeno, Naoto ^a   Konno, Masatoshi ^a   Takeda, Atsushi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

123l myocardial meta iodobenzylguanidine (MIBG) myocardial scintigraphy; Multiple system atrophy (MSA); Olfactory test; Parkinson's disease (PD)

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; ARTICLE; CEREBELLAR ATAXIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; FEMALE; FUNCTION TEST; HUMAN; IMAGE ANALYSIS; MALE; MYOCARDIAL PERFUSION IMAGING; ODOR STICK IDENTIFICATION TEST FOR JAPANESE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; SMELL TEST;

3-IODOBENZYLGUANIDINE; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; MYOCARDIAL PERFUSION IMAGING; OLFACTION DISORDERS; PARKINSON DISEASE; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 81155159731     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.07.011     Document Type: Article

References (8)

1. Lee P.H., Yeo S.H., Kim H.J., Youm H.Y. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Mov Disord 2006, 21:1975-1977.
2. Orimo S., Ozawa E., Nakade S., Sugimoto T., Mizusawa H. 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999, 67:189-194.
3. Wenning G.K., Shephard B., Hawkes C., Petruckevitch A., Lees A., Quinn N. Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 1995, 91:247-250.
4. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988, 51:745-752.
5. Gilman S., Wenning G.K., Low P.A., Brooks D.J., Mathias C.J., Trojanowski J.Q., et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71:670-676.
6. Kobayashi M., Reiter E.R., DiNardo L.J., Costanzo R.M. A new clinical olfactory function test: cross-cultural influence. Arch Otolaryngol Head Neck Surg 2007, 133:331-336.
7. Goldstein D.S., Holmes C., Bentho O., Sato T., Moak J., Sharabi Y., et al. Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism Relat Disord 2008, 14:600-607.
8. Sawada H., Oeda T., Yamamoto K., Kitagawa N., Mizuta E., Hosokawa R., et al. Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. Eur J Neurol 2009, 16:174-182.